p>
December 29, September 29,
2007 2007
CURRENT ASSETS:
Cash and cash equivalents $189,329 $100,403
Accounts receivable, net 288,404 152,743
Inventories 150,070 105,289
Deferred income tax asset 36,763 29,356
Prepaid expenses and other current assets 88,313 11,389
Total current assets 752,879 399,180
Property and equipment, net 258,741 69,769
Intangible assets, net 2,630,245 174,361
Goodwill, net 4,191,182 407,528
Other assets, net 65,581 15,511
$7,898,628 $1,066,349
LIABILITIES AND STOCKHOLDERS' EQUITY
December 29, September 29,
2007 2007
CURRENT LIABILITIES:
Current portion of notes payable $2,914 $1,977
Accounts payable 60,104 42,289
Accrued expenses 127,049 88,577
Deferred revenue 60,333 45,769
Total current liabilities 250,400 178,612
Notes payable, net of current portion 304,980 9,222
Convertible debt 1,728,694 -
Deferred tax liabilities 945,470 54,866
Deferred revenue 9,985 10,135
Other long term lia
'/>"/>
SOURCE Hologic, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Related biology technology :1.
Hologic, Inc. to Release First Quarter Fiscal 2008 Operating Results Thursday, January 31st Before Market Opens2.
Hologic to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference3.
Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients4.
YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 265.
Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering6.
BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.7.
Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets8.
China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results9.
Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain10.
Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter11.
ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer